A Potential Shift From Adaptive Immune Activity to Nonspecific Inflammatory Activation Associated With Higher Depression Symptoms in Chronic Heart Failure Patients

Journal of Cardiac Failure

Volumn 15, Issue 7, 2009, Pages 607-615

  Redwine, Laura S ^a,b   Wirtz, Petra H ^c   Hong, Suzi ^a   Pandzic, Ines ^b   Cammarata, Stephanie ^b   Tafur, Joseph ^a   Carter, Steven M ^b   Greenberg, Barry ^b   Mills, Paul J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

depression; dysregulation; heart failure; Immune

Indexed keywords

FORMYLMETHIONYLLEUCYLPHENYLALANINE; STROMAL CELL DERIVED FACTOR 1;

ADAPTIVE IMMUNITY; ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CHEMOTAXIS; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HEART FAILURE; HUMAN; HUMAN CELL; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SYMPTOM;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; DEPRESSION; EXERCISE TEST; FEMALE; HEART FAILURE; HUMANS; IMMUNITY, ACTIVE; INFLAMMATION; MALE; MIDDLE AGED;

EID: 68849094830     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.01.011     Document Type: Article

References (66)

1. Jiang W., Kuchibhatla M., Cuffe M.S., Christopher E.J., Alexander J.D., Clary G.L., et al. Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation 110 (2004) 3452-3456
2. Sullivan M., Levy W.C., Russo J.E., and Spertus J.A. Depression and health status in patients with advanced heart failure: a prospective study in tertiary care. J Card Fail 10 (2004) 390-396
3. Junger J., Schellberg D., Muller-Tasch T., Raupp G., Zugck C., Haunstetter A., et al. Depression increasingly predicts mortality in the course of congestive heart failure. Eur J Heart Fail 7 (2005) 261-267
4. Rutledge T., Reis V.A., Linke S.E., Greenberg B.H., and Mills P.J. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 48 (2006) 1527-1537
5. Sherwood A., Blumenthal J.A., Trivedi R., Johnson K.S., O'Connor C.M., Adams K.F., et al. Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med 167 (2007) 367-373
6. Irwin M., Thompson J., Miller C., Gillin J.C., and Ziegler M. Effects of sleep and sleep deprivation on catecholamine and interleukin-2 levels in humans: clinical implications. J Clin Endocrinol Metab 84 (1999) 1979-1985
7. Moorman A.J., Mozaffarian D., Wilkinson C.W., Lawler R.L., McDonald G.B., Crane B.A., et al. In patients with heart failure elevated soluble TNF-receptor 1 is associated with higher risk of depression. J Card Fail 13 (2007) 738-743
8. Lesperance F., Frasure-Smith N., Theroux P., and Irwin M. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry 161 (2004) 271-277
9. Miller G.E., Freedland K.E., and Carney R.M. Depressive symptoms and the regulation of proinflammatory cytokine expression in patients with coronary heart disease. J Psychosom Res 59 (2005) 231-236
10. Suarez E.C., Lewis J.G., Krishnan R.R., and Young K.H. Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women. Psychoneuroendocrinology 29 (2004) 1119-1128
11. Ferketich A., Ferguson J.P., and Binkley P.F. Depressive symptoms and inflammation among heart failure patients. Am Heart J 150 (2005) 132-136
12. Whooley M.A., Caska C.M., Hendrickson B.E., Rourke M.A., Ho J., and Ali S. Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol Psychiatry 62 (2007) 314-320
13. Lanquillon S., Krieg J.C., Bening-Abu-Shach U., and Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22 (2000) 370-379
14. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 15 (2001) 199-226
15. Waldman W.J., Williams Jr. M.V., Lemeshow S., Binkley P., Guttridge D., Kiecolt-Glaser J.K., et al. Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: evidence for depression-induced atherosclerotic risk. Brain Behav Immun 22 (2008) 215-223
16. de Virginy D. Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure: a clinical review. Heart Fail Rev 11 (2006) 333-334
17. Mielniczuk L.M., and Baughman K.L. Immune modulation therapy in heart failure. Congest Heart Fail 12 (2006) 91-96 quiz 97-98
18. Reiche E.M., Nunes S.O., and Morimoto H.K. Stress, depression, the immune system, and cancer. Lancet Oncol 5 (2004) 617-625
19. Irwin M., Costlow C., Williams H., Artin K.H., Chan C.Y., Stinson D.L., et al. Cellular immunity to varicella-zoster virus in patients with major depression. J Infect Dis 178 Suppl 1 (1998) S104-S108
20. Afanasyeva M., Georgakopoulos D., Belardi D.F., Bedja D., Fairweather D., Wang Y., et al. Impaired up-regulation of CD25 on CD4+ T cells in IFN-gamma knockout mice is associated with progression of myocarditis to heart failure. Proc Natl Acad Sci 102 (2005) 180-185
21. Shimbo D., Chaplin W., Crossman D., Haas D., and Davidson K.W. Role of depression and inflammation in incident coronary heart disease events. Am J Cardiol 96 (2005) 1016-1021
22. Empana J., Sykes D.H., Luc G., Juhan-Vague I., Arveiler D., Ferrieres J., et al. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 111 (2005) 2299-2305
23. Opasich C., Pacini F., Ambrosino N., Riccardi P.G., Febo O., Ferrari R., et al. Sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure. Eur Heart J 17 (1996) 1860-1866
24. Szabo M.C., Butcher E.C., McIntyre B.W., Schall T.J., and Bacon K.B. RANTES stimulation of T lymphocyte adhesion and activation: role for LFA-1 and ICAM-3. Eur J Immunol 27 (1997) 1061-1068
25. Chen J., Fujimoto C., Vistica B.P., He J., Wawrousek E.F., Kelsall B., et al. Active participation of antigen-nonspecific lymphoid cells in immune-mediated inflammation. J Immunol 177 (2006) 3362-3368
26. Adamopoulos S., Parissis J., Kroupis C., Georgiadis M., Karatzas D., Karavolias G., Koniavitou K., et al. Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. Eur Heart J 22 (2001) 791-797
27. Pyo R.T., Sui J., Dhume A., Palomeque J., Blaxall B.C., Diaz G., et al. CXCR4 modulates contractility in adult cardiac myocytes. J Mol Cell Cardiol 41 (2006) 834-844
28. Frangogiannis N.G., Dewald O., Xia Y., Ren G., Haudek S., Leucker T., et al. Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation 115 (2007) 584-592
29. Linden W., Gerin W., and Davidson K. Cardiovascular reactivity: status quo and a research agenda for the new millennium. Psychosom Med 65 (2003) 5-8
30. Kop W.J., Weissman N.J., Zhu J., Bonsall R.W., Doyle M., Stretch M.R., et al. Effects of acute mental stress and exercise on inflammatory markers in patients with coronary artery disease and healthy controls. Am J Cardiol 101 (2008) 767-773
31. Chung I., Goyal D., Macfadyen R.J., and Lip G.Y. The effects of maximal treadmill graded exercise testing on haemorheological, haemodynamic and flow cytometry platelet markers in patients with systolic or diastolic heart failure. Eur J Clin Invest 38 (2008) 150-158
32. Pace T.W., Mletzko T.C., Alagbe O., Musselman D.L., Nemeroff C.B., Miller A.H., et al. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry 163 (2006) 1630-1633
33. O'Keeffe S.T., Lye M., Donnellan C., and Carmichael D.N. Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients. Heart 80 (1998) 377-382
34. Redwine L.S., Pert C.B., Rone J.D., Nixon R., Vance M., Sandler B., et al. Peptide T blocks GP120/CCR5 chemokine receptor-mediated chemotaxis. Clinical Immunol 93 (1999) 124-131
35. Batista Jr. M.L., Santos R.V., Cunha L.M., Mattos K., Oliveira E.M., Seelaender M.C., et al. Changes in the pro-inflammatory cytokine production and peritoneal macrophage function in rats with chronic heart failure. Cytokine 34 (2006) 284-290
36. Zalai C.V., Kolodziejczyk M.D., Pilarski L., Christov A., Nation P.N., Lundstrom-Hobman M., et al. Increased circulating monocyte activation in patients with unstable coronary syndromes. J Am Coll Cardiol 38 (2001) 1340-1347
37. Ding Z., Issekutz T.B., Downey G.P., and Waddell T.K. L-selectin stimulation enhances functional expression of surface CXCR4 in lymphocytes: implications for cellular activation during adhesion and migration. Blood 101 (2003) 4245-4252
38. Nanki T., and Lipsk P.E. Cutting edge: stromal cell-derived factor-1 is a costimulator for CD4+ T cell activation. J Immunol 164 (2000) 5010-5014
39. Vicente-Manzanaares M., Montoya M.C., Mellado M., Frade J.M.R., del Pozo M.A., Nieto M., et al. The chemokine SDF-1 alpha triggers a chemotactic response and induces cell polarization in human B lymphocytes. Eur J Immunol 28 (1998) 2197-2207
40. Redwine L., Snow S., Mills P., and Irwin M. Acute psychological stress: effects on chemotaxis and cellular adhesion molecule expression. Psychosom Med 65 (2003) 598-603
41. Redwine L., et al. Differential immune cell chemotaxis responses to acute psychological stress in Alzheimer caregivers compared to non-caregiver controls. Psychosom Med 66 (2004) 770-775
42. Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 2 (1970) 92-98
43. Hong S., Johnson T.A., Farag N.H., Guy H.J., Matthews S.C., Ziegler M.G., et al. Attenuation of T-lymphocyte demargination and adhesion molecule expression in response to moderate exercise in physically fit individuals. J Appl Physiol 98 (2005) 1057-1063
44. Hong S., and Mills P.J. Effects of an exercise challenge on mobilization and surface marker expression of monocyte subsets in individuals with normal vs. elevated blood pressure. Brain Behav Immun 22 (2008) 590-599
45. Beck A.T. Depression inventory (1978), Center for Cognitive Therapy, Philadelphia
46. Beck A.T., Steer R.A., Ball R., and Ranieri W. Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J Pers Assess 67 (1996) 588-597
47. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Association, Washington DC
48. Baron R.M., and Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51 (1986) 1173-1182
49. Fairweather D., Frisancho-Kiss S., Yusung S.A., Barrett M.A., Davis S.E., Gatewood S.J., et al. Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. Am J Pathol 165 (2004) 1883-1894
50. Bandura A. Health promotion by social cognitive means. Health Educ Behav 31 (2004) 143-164
51. Dadfar E., Jacobson S.H., and Lundahl J. Newly recruited human monocytes have a preserved responsiveness towards bacterial peptides in terms of CD11b up-regulation and intracellular hydrogen peroxide production. Clin Exp Immunol 148 (2007) 573-582
52. Luethviksson B.R., and Gunnlaugsdottir B. Transforming growth factor-beta as a regulator of site-specific T-cell inflammatory response. Scand J Immunol 58 (2003) 129-138
53. Stein J.V., and Nombela-Arrieta C. Chemokine control of lymphocyte trafficking: a general overview. Immunology 116 (2005) 1-12
54. Woo Y.J., Grand T.J., Berry M.F., Atluri P., Moise M.A., Hsu V.M., et al. Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy. J Thorac Cardiovasc Surg 130 (2005) 321-329
55. Anderson C.D., Heydarkhan-Hagvall S., Schenke-Layland K., Yang J.Q., Jordan M.C., Kim J.K., et al. The role of cytoprotective cytokines in cardiac ischemia/reperfusion injury. J Surg Res 148 (2008) 164-171
56. Valgimigli M., Rigolin G.M., Fucili A., Porta M.D., Soukhomovskaia O., Malagutti P., et al. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 110 (2004) 1209-1212
57. Frantz S., Bauersachs J., and Kelly R.A. Innate immunity and the heart. Curr Pharm Des 11 (2005) 1279-1290
58. Wirtz P.H., Hong S., Redwine L.S., Tafur J., Rutledge T., Ziegler M.G., et al. Depressive symptoms are associated with soluble p-selectin reactivity to acute exercise in heart failure. Biol Psychiatry (2008) Dec; [Epub ahead of print]
59. Sela U., Hershkoviz R., Cahalon L., Lider O., and Mozes E. Down-regulation of stromal cell-derived factor-1alpha-induced T cell chemotaxis by a peptide based on the complementarity-determining region 1 of an anti-DNA autoantibody via up-regulation of TGF-beta secretion. J Immunol 174 (2005) 302-309
60. Debes G.F., Dahl M.E., Mahiny A.J., Bonhagen K., Campbell D.J., Siegmund K., et al. Chemotactic responses of IL-4-, IL-10-, and IFN-gamma-producing CD4+ T cells depend on tissue origin and microbial stimulus. J Immunol 176 (2006) 557-566
61. Pavon L., Sandoval-Lopez G., Hernandez M., Loria F., Estrada I., Perez M., et al. Th2 cytokine response in major depressive disorder patients before treatment. J Neuroimmunol 172 (2006) 156-165
62. Kim Y.K., Na K.S., Shin K.H., Jung H.Y., Choi S.H., and Kim J.B. Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 1044-1053
63. Redwine L., Mills P.J., Hong S., Rutledge T., Reis V., Maisel A., et al. Cardiac-related hospitalization and/or death associated with immune dysregulation and symptoms of depression in heart failure patients. Psychosom Med 69 (2007) 23-29
64. Miller G., Freedland K.E., and Carney R.M. Depressive symptoms and the regulation of proinflammatory cytokine expression in patients with coronary heart disease. J Psychosom Res 59 (2005) 231-236
65. Straub R.H., Mayer M., Kreutz M., Leeb S., Scholmerich J., and Falk W. Neurotransmitters of the sympathetic nerve terminal are powerful chemoattractants for monocytes. J Leukoc Biol 67 (2000) 553-558
66. Garcia J.J., del Carmen Saez M., De la Fuente M., and Ortega E. Regulation of phagocytic process of macrophages by noradrenaline and its end metabolite 4-hydroxy-3-metoxyphenyl-glycol. Role of alpha- and beta-adrenoreceptors. Mol Cell Biochem 254 (2003) 299-304